SARMs Capsule SARMs Powder stenabolic sR9009 Synthetic Anabolic Steroids For Muscle Growth

Product Description

Stenabolic SR9009 SARMs Powder Synthetic Anabolic Steroids To Lose Weight CAS 1379686-30-2

What is Stenabolic (SR9009)?

SR9009, also known as Stenabolic, was developed by The Scripps Research Institute under the leadership of Professor Thomas Burris.

Although related to SARMS, Stenabolic (SR9009) is actually a Rev-ErbA ligand. This means that SR binds to this protein and makes it more active. As a result, users will experience many positive effects such as increased fat loss, enhanced stamina and many other health benefits.

As previously mentioned, SR9009 is a synthetic Rev-Erb ligand that is orally available. This is a very unique compound. By stimulating the Rev-Erb protein, SR9009 is able to greatly affect many regulatory mechanisms in the human body.

For example, it can affect circadian rhythms, lipid and glucose metabolism, fat storage cells, and macrophages. Therefore, Stenabolic will allow users to lose fat and significantly improve endurance, both of which are very desirable effects for athletes.

Description:

SR9009, currently under development at The Scripps Research Institute (TSRI), increases metabolic activity levels in mouse skeletal muscle. Treated mice became lean, muscular, and were able to run longer distances simply by taking SR9009, which mimics the effects of aerobic exercise. If similar effects could be achieved in humans, reversing obesity, metabolic syndrome, and perhaps type 2 diabetes could be a very welcome outcome.
The drug was developed by Professor Thomas Burris, who found it was able to reduce obesity in a population of mice. It binds and activates a protein called Rev-ErbAα, which affects fat and sugar burning in the liver, production of fat cells, and the body's inflammatory response.
refer to
If the effects of SR9009 in mice can be safely replicated in humans, the new drug may provide new treatments for obesity and its accompanying diseases, metabolic syndrome and diabetes. Another area where SR9009 or similar drugs could provide significant benefit is in counteracting the loss of general muscle regulation, which is a side effect of decreased activity due to disease and/or aging. Those most likely to enjoy these benefits include those with severe arthritis, congestive heart failure, chronic obstructive pulmonary disease (COPD) and other conditions that limit the ability to exercise.

Commerce Clause

Applications:

SR9009 (Stenabolic) is able to alter the activity of skeletal muscle mitochondria, or to put it simply - it increases your metabolic activity. This makes it similar to what DNP does, the SR9009 is safer and won't backfire on your stamina goals. What's more, unlike DNP, the SR9009 is capable of simulating actual aerobic exercise without actual conditioning. Therefore, it increases your stamina instead of hurting it.

Stenabolic (SR9009) binds to a protein called Rev-erbA. This is important because this protein affects fat and sugar burning in the liver, the production of fat cells, and the body's inflammatory response. Therefore, this interplay between the SR9009 and Rev-erbA allows you to make your current workout team more effective. In fact, even sitting on your butt all day won't get in the way of your goals. All in all, the ultimate goal is to burn energy from what you eat rather than store it as fat, which SR does well. Also, it attacks existing fat and burns it off.

Stenabolic (SR9009) will help a person get slimmer, it will help them do longer distances during cardio without curling up as quickly. Overall, it will increase your VO2 max and thus your stamina.

In addition, SR9009 may also benefit non-athletes as it reverses obesity, metabolic syndrome and type 2 diabetes.

The developers used mice with low muscle mass, a low metabolic rate, and poor running ability. So the mouse is basically the human version of the shape-shifting couch potato. Once Stenabolic is given, muscle and metabolic rates increase, even when exercise is not allowed. Then, once the mice were allowed to exercise, they were able to run another 50 percent without feeling out of breath.

How it works?

SR9009 treatment was shown to increase endurance and reverse mitochondrial damage in studies.
SR9009 has great promise in increased exercise capacity and endurance. This compound acts as an agonist of Rev-erbα. SR9009 binds to one of the body's natural molecules called Rev-erbα, which influences lipid and glucose metabolism in the liver, the production of fat-storing cells and the response of macrophages (cells that remove dying or dead cells) during inflammation.

Current studies show activation of Rev-erbα with SR9009 led to increased metabolic activity in skeletal muscle in culture,had a 50 percent increase in running capacity, measured by both time and distance.
SR9009 is an easy to dose oral compound that boosts metabolic activity in current studies.
SR9009 latches onto Rev-erbα -- which plays a role in regulating the body's circadian rhythm and metabolism -- resulting in a pronounced metabolic boost in test subjects.

SR9009 Dosages and Suggestion

Dosages of 20-100mg a day have been reported by users without any negative side effects. From the information we have received, results from SR9009 treatment appear to be dose dependent up to a maximum dosage of 100mg per day. After this dosage, results tend to taper off.

Stenabolic SR9009 SARMs Powder Synthetic Anabolic Steroids To Lose Weight CAS 1379686-30-2